VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit
Core
Strategically lead the global development of GSK's cancer vaccine medicine(s) from C2P2 through approval and launch across major markets, acting as the single point of accountability for the asset.
Role type
VP, Medicine Development Leader (MDL) – Cancer Vaccines
Builds
Cancer vaccine medicines for patients with unmet oncology needs
Domain
Oncology / Immuno-oncology / Biotechnology
Required skills
Oncology drug development expertise, global pharmaceutical/biotechnology industry experience, leading successful development and registration of medicines, experience with cancer vaccines/therapeutic vaccines/immuno-oncology combination products, BLA/NDA/MAA filing experience, R&D across development/commercial life cycle, leading teams in complex matrixed global organizations, regulatory experience with novel vaccine modalities, P&L management, budget planning
Preferred skills
Personalized medicine experience
Technologies
mRNA, neoantigen prediction, personalized vaccine manufacturing
Responsibilities
Define strategic vision and operational plan for cancer vaccine medicine, create and lead multi-disciplinary Medicine Development Team (MDT), establish compelling vision within GSK's Oncology R&D strategy, deliver differentiated cancer vaccine medicines through evidence package, prioritize and maximize asset's portfolio options, embed core processes including cost efficiency and compliance, identify and align resources, enhance patient focus, engage and negotiate with internal and external stakeholders, serve as asset's single point of contact to senior management and boards, manage asset resourcing plan and budget, develop ongoing patent strategy, partner with Business Development for alternative business strategies
Seniority
VP, strategic leadership with high accountability